Page last updated: 2024-10-22

alprenolol and Myotonic Dystrophy

alprenolol has been researched along with Myotonic Dystrophy in 1 studies

Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, Y1
Kondo, Y1
Takano, M1

Other Studies

1 other study available for alprenolol and Myotonic Dystrophy

ArticleYear
[Anesthetic management in dystrophia myotonica].
    Masui. The Japanese journal of anesthesiology, 1972, Volume: 21, Issue:2

    Topics: Adult; Alprenolol; Anesthesia; Ephedrine; Female; Halothane; Humans; Laminectomy; Ligaments; Myotoni

1972